Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 10/20 | 0.42 |
| ▸ | PGR | P06401 | 4/20 | 0.42 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.41 |
| ▸ | DPP4 | P27487 | 2/20 | 0.36 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.36 |
| ▸ | CLK1 | P49759 | 1/20 | 0.36 |
| ▸ | CLK2 | P49760 | 1/20 | 0.36 |
| ▸ | SRPK2 | P78362 | 1/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.36 |
| ▸ | SRPK1 | Q96SB4 | 1/20 | 0.36 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.36 |
| ▸ | SRPK3 | Q9UPE1 | 1/20 | 0.36 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15763525 | 1.00 | ALK (0.42) | ALKPGRPDK2DPP4DYRK3 | |
| SCHEMBL15763515 | 0.99 | PGR (0.43) | ALKPGRPDK2DPP4DYRK3 | |
| SCHEMBL15763519 | 0.98 | PGR (0.44) | ALKPGRPDK2DPP4DYRK3 | |
| SCHEMBL15763521 | 0.98 | PGR (0.44) | ALKPGRPDK2DPP4DYRK3 | |
| SCHEMBL15763528 | 0.96 | ALK (0.44) | ALKPGRPDK2SRPK2SRPK1 | |
| SCHEMBL15763477 | 0.95 | PGR (0.42) | ALKPGRPDK2DYRK3CLK1 | |
| SCHEMBL15763510 | 0.94 | PGR (0.45) | ALKPGRPDK2DYRK3CLK1 | |
| SCHEMBL15763483 | 0.94 | PGR (0.44) | ALKPGRPDK2DYRK3CLK1 | |
| SCHEMBL15763509 | 0.94 | PGR (0.47) | ALKPGRPDK2ALDH1A1ATM | |
| SCHEMBL18193666 | 0.93 | ALK (0.38) | ALKPGRPDK2DPP4DYRK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9818951-B2 | Polycyclic compound and organic electronic device comprising the same | LG CHEM, LTD. (KR) | 2017-11-14 | — | — | US | disclosed |
| US-9818951-B2 | Polycyclic compound and organic electronic device comprising the same | LG CHEM, LTD. (KR) | 2017-11-14 | — | — | US | disclosed |
| US-20160329500-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | LG CHEM LTD. (KR) | 2016-11-10 | — | — | US | disclosed |
| US-20160329500-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | LG CHEM LTD. (KR) | 2016-11-10 | — | — | US | disclosed |
| US-9484539-B2 | Polycyclic compound and organic electronic device comprising the same | LG CHEM, LTD. (KR) | 2016-11-01 | — | — | US | disclosed |
| US-9484539-B2 | Polycyclic compound and organic electronic device comprising the same | LG CHEM, LTD. (KR) | 2016-11-01 | — | — | US | disclosed |
| US-20140151670-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2014-06-05 | — | — | US | disclosed |
| US-20140151670-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2014-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160329500-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | PIEZO1, EED, ETV6 | ALK 287/4885PGR 603/4885PDK2 2576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.